PHAT (Phathom Pharmaceuticals) Short Interest


PHAT Phathom Pharmaceuticals Inc PHAT
25 GF Score
Price $10.61
! 3 Warning Signs
View Full Analysis

What is Phathom Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

PHAT vs AURA, RLMD, SMNR: Short Interest Comparison

For the Biotechnology subindustry, Phathom Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phathom Pharmaceuticals Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Phathom Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Phathom Pharmaceuticals's Short Interest falls into.


PHAT
25GF Score
Phathom Pharmaceuticals Inc PHAT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phathom Pharmaceuticals Business Description

Address 100 Campus Drive, Suite 102, Florham Park, NJ, USA, 07932
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
25GF Score

Get the complete analysis for PHAT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.61
Price